These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1514 related articles for article (PubMed ID: 29225343)

  • 1. Advances in the understanding and treatment of sepsis-induced immunosuppression.
    Venet F; Monneret G
    Nat Rev Nephrol; 2018 Feb; 14(2):121-137. PubMed ID: 29225343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid cells in sepsis-acquired immunodeficiency.
    Venet F; Demaret J; Gossez M; Monneret G
    Ann N Y Acad Sci; 2021 Sep; 1499(1):3-17. PubMed ID: 32202669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advances in sepsis induced immunosuppression and immunomodulation therapy].
    He X; Bo L; Jiang C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Dec; 30(12):1202-1205. PubMed ID: 30592959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
    Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
    Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial.
    Meisel C; Schefold JC; Pschowski R; Baumann T; Hetzger K; Gregor J; Weber-Carstens S; Hasper D; Keh D; Zuckermann H; Reinke P; Volk HD
    Am J Respir Crit Care Med; 2009 Oct; 180(7):640-8. PubMed ID: 19590022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sepsis-induced immune alterations monitoring by flow cytometry as a promising tool for individualized therapy.
    Monneret G; Venet F
    Cytometry B Clin Cytom; 2016 Jul; 90(4):376-86. PubMed ID: 26130241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression.
    Patil NK; Bohannon JK; Sherwood ER
    Pharmacol Res; 2016 Sep; 111():688-702. PubMed ID: 27468649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunomodulation for sepsis: a change of tack?].
    Leentjens J; Kox M; Pickkers P
    Ned Tijdschr Geneeskd; 2014; 158():A6859. PubMed ID: 24518844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of granulocyte-monocyte colony-stimulating factor therapy on leukocyte function and clearance of serious infection in nonneutropenic patients.
    Rosenbloom AJ; Linden PK; Dorrance A; Penkosky N; Cohen-Melamed MH; Pinsky MR
    Chest; 2005 Jun; 127(6):2139-50. PubMed ID: 15947332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sepsis Induces Prolonged Epigenetic Modifications in Bone Marrow and Peripheral Macrophages Impairing Inflammation and Wound Healing.
    Davis FM; Schaller MA; Dendekker A; Joshi AD; Kimball AS; Evanoff H; Wilke C; Obi AT; Melvin WJ; Cavassani K; Scola M; Carson B; Moser S; Blanc V; Engoren M; Moore BB; Kunkel SL; Gallagher KA
    Arterioscler Thromb Vasc Biol; 2019 Nov; 39(11):2353-2366. PubMed ID: 31644352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-7 and anti-programmed cell death 1 antibody have differing effects to reverse sepsis-induced immunosuppression.
    Shindo Y; Unsinger J; Burnham CA; Green JM; Hotchkiss RS
    Shock; 2015 Apr; 43(4):334-43. PubMed ID: 25565644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDSCs in sepsis-induced immunosuppression and its potential therapeutic targets.
    Zhang W; Fang X; Gao C; Song C; He Y; Zhou T; Yang X; Shang Y; Xu J
    Cytokine Growth Factor Rev; 2023 Feb; 69():90-103. PubMed ID: 35927154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer?
    Boomer JS; Green JM; Hotchkiss RS
    Virulence; 2014 Jan; 5(1):45-56. PubMed ID: 24067565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte-macrophage colony-stimulating factor drives monocytes to CD14low CD83+ DCSIGN- interleukin-10-producing myeloid cells with differential effects on T-cell subsets.
    Ganguly D; Paul K; Bagchi J; Rakshit S; Mandal L; Bandyopadhyay G; Bandyopadhyay S
    Immunology; 2007 Aug; 121(4):499-507. PubMed ID: 17433076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortality.
    Presneill JJ; Waring PM; Layton JE; Maher DW; Cebon J; Harley NS; Wilson JW; Cade JF
    Crit Care Med; 2000 Jul; 28(7):2344-54. PubMed ID: 10921563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte colony-stimulating factor as the expecting sword for the treatment of severe sepsis.
    Murata A
    Curr Pharm Des; 2003; 9(14):1115-20. PubMed ID: 12769751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte anergy is present in patients with severe acute pancreatitis and is significantly alleviated by granulocyte-macrophage colony-stimulating factor and interferon-gamma in vitro.
    Kylanpaa ML; Mentula P; Kemppainen E; Puolakkainen P; Aittomaki S; Silvennoinen O; Haapiainen R; Repo H
    Pancreas; 2005 Jul; 31(1):23-7. PubMed ID: 15968243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice.
    Bundschuh DS; Barsig J; Hartung T; Randow F; Döcke WD; Volk HD; Wendel A
    J Immunol; 1997 Mar; 158(6):2862-71. PubMed ID: 9058823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sepsis-induced immunosuppression: from bad to worse.
    Reddy RC; Chen GH; Tekchandani PK; Standiford TJ
    Immunol Res; 2001; 24(3):273-87. PubMed ID: 11817325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response of severely injured patients--influence of surgical intervention and therapeutic impact.
    Flohé S; Flohé SB; Schade FU; Waydhas C
    Langenbecks Arch Surg; 2007 Sep; 392(5):639-48. PubMed ID: 17605036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 76.